Dual and Triple Agonists Tirzepatide (Mounjaro/Zepbound) Tirzepatide is the first true dual or co-agonist, activating both GLP-1 and GIP receptors, a pairing often called a twincretin
This triple activation is what makes it so effective for fat loss , with Phase 2 data showing up to 24% body weight reduction
like LCMS/MS 15,16,17,18,19,20,21 , LC-UV 22,23,24,25,26 and capillary electrophoresis 27,28,29
Our findings highlight the need to develop supplements or interventions to lower palmitoyl-L-carnitine synthesis or levels as a promising treatment approach
Despite these alarming figures, obesity is a modifiable risk factor which means it can be reversed
If youre ready to explore peptide therapy safely, reach out to VYVE Wellness today to learn more about how our tailored treatments can help you achieve your health goals!